The therapeutic effects of transferring remote ischemic preconditioning serum in rats with neuropathic pain symptoms

Background and objectives: Neuropathic pain is defined as pain caused by damage to the nerve as a result of a lesion or disease. It has been shown that ischemic preconditioning exerts a protective role in various tissue injuries; however, the effect of transplantation of remote ischemic precondition...

Full description

Bibliographic Details
Main Authors: Ozgur Gunduz, Zekiye Gulfem Yurtgezen, Ruhan Deniz Topuz, Melike Sapmaz-Metin, Oktay Kaya, Abdullah Erkan Orhan, Ahmet Ulugol
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023081628
_version_ 1797646458854309888
author Ozgur Gunduz
Zekiye Gulfem Yurtgezen
Ruhan Deniz Topuz
Melike Sapmaz-Metin
Oktay Kaya
Abdullah Erkan Orhan
Ahmet Ulugol
author_facet Ozgur Gunduz
Zekiye Gulfem Yurtgezen
Ruhan Deniz Topuz
Melike Sapmaz-Metin
Oktay Kaya
Abdullah Erkan Orhan
Ahmet Ulugol
author_sort Ozgur Gunduz
collection DOAJ
description Background and objectives: Neuropathic pain is defined as pain caused by damage to the nerve as a result of a lesion or disease. It has been shown that ischemic preconditioning exerts a protective role in various tissue injuries; however, the effect of transplantation of remote ischemic preconditioning serum (RIPCs) on neuropathic pain symptoms has not been studied. The aim of this project is to investigate the effect of RIPCs transfusion by different routes of administration on neuropathic pain symptoms. Our secondary aim was to demonstrate the role of Schwann cells in the regeneration of sciatic nerve injury and to evaluate the change in the number of glial cells in the spinal cord dorsal horn. Methods: The sciatic nerve partial ligation method was used to induce neuropathic pain. Changes in neuropathic pain symptoms were assessed by measuring thermal hyperalgesia and mechanical allodynia. To determine the possible therapeutic site, alterations in the number of spinal cord lumbar posterior horn microglia and astrocytes were evaluated by ionized calcium-binding adapter molecule 1 (iba1) and glial fibrillary acidic protein (GFAP) immunostaining. Myelin basic protein immunohistochemistry was also used to assess Schwann cell immunoreactivity in the sciatic nerve. Results: In rats that underwent partial sciatic nerve ligation, neuropathic pain symptoms developed on average on day 12 and persisted up to day 21 (p < 0.0001). RIPCs administered intravenously for five days reduced thermal hyperalgesia more than intraperitoneal and subcutaneous administration (p < 0.05). Both central glial cells appear to play a role in the effect of RIPCs. RIPCs treatment increases Schwann cell remyelination. Conclusions: Our results showed that intravenously administered RIPCs remarkably improved the neuropathic pain symptoms, thermal hyperalgesia and mechanical allodynia. Further studies are needed to evaluate the role of RIPCs transfusion on glial cells.
first_indexed 2024-03-11T15:01:53Z
format Article
id doaj.art-8b1159b9d250425ab91f5813ba3bf781
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-11T15:01:53Z
publishDate 2023-10-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-8b1159b9d250425ab91f5813ba3bf7812023-10-30T06:07:57ZengElsevierHeliyon2405-84402023-10-01910e20954The therapeutic effects of transferring remote ischemic preconditioning serum in rats with neuropathic pain symptomsOzgur Gunduz0Zekiye Gulfem Yurtgezen1Ruhan Deniz Topuz2Melike Sapmaz-Metin3Oktay Kaya4Abdullah Erkan Orhan5Ahmet Ulugol6Department of Medical Pharmacology, Faculty of Medicine, Trakya University, Edirne, Turkey; Corresponding author. Trakya University, Faculty of Medicine, Department of Medical Pharmacology, 22030, Edirne, Turkey.Department of Histology and Embryology, Faculty of Medicine, Trakya University, TurkeyDepartment of Medical Pharmacology, Faculty of Medicine, Trakya University, Edirne, TurkeyDepartment of Histology and Embryology, Faculty of Medicine, Trakya University, TurkeyDepartment of Physiology, Faculty of Medicine, Trakya University, Edirne, TurkeyDepartment of Plastic Surgery, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, TurkeyDepartment of Medical Pharmacology, Faculty of Medicine, Trakya University, Edirne, TurkeyBackground and objectives: Neuropathic pain is defined as pain caused by damage to the nerve as a result of a lesion or disease. It has been shown that ischemic preconditioning exerts a protective role in various tissue injuries; however, the effect of transplantation of remote ischemic preconditioning serum (RIPCs) on neuropathic pain symptoms has not been studied. The aim of this project is to investigate the effect of RIPCs transfusion by different routes of administration on neuropathic pain symptoms. Our secondary aim was to demonstrate the role of Schwann cells in the regeneration of sciatic nerve injury and to evaluate the change in the number of glial cells in the spinal cord dorsal horn. Methods: The sciatic nerve partial ligation method was used to induce neuropathic pain. Changes in neuropathic pain symptoms were assessed by measuring thermal hyperalgesia and mechanical allodynia. To determine the possible therapeutic site, alterations in the number of spinal cord lumbar posterior horn microglia and astrocytes were evaluated by ionized calcium-binding adapter molecule 1 (iba1) and glial fibrillary acidic protein (GFAP) immunostaining. Myelin basic protein immunohistochemistry was also used to assess Schwann cell immunoreactivity in the sciatic nerve. Results: In rats that underwent partial sciatic nerve ligation, neuropathic pain symptoms developed on average on day 12 and persisted up to day 21 (p < 0.0001). RIPCs administered intravenously for five days reduced thermal hyperalgesia more than intraperitoneal and subcutaneous administration (p < 0.05). Both central glial cells appear to play a role in the effect of RIPCs. RIPCs treatment increases Schwann cell remyelination. Conclusions: Our results showed that intravenously administered RIPCs remarkably improved the neuropathic pain symptoms, thermal hyperalgesia and mechanical allodynia. Further studies are needed to evaluate the role of RIPCs transfusion on glial cells.http://www.sciencedirect.com/science/article/pii/S2405844023081628Neuropathic painRemote ischemic preconditioningHyperalgesiaAllodyniaGlial cells
spellingShingle Ozgur Gunduz
Zekiye Gulfem Yurtgezen
Ruhan Deniz Topuz
Melike Sapmaz-Metin
Oktay Kaya
Abdullah Erkan Orhan
Ahmet Ulugol
The therapeutic effects of transferring remote ischemic preconditioning serum in rats with neuropathic pain symptoms
Heliyon
Neuropathic pain
Remote ischemic preconditioning
Hyperalgesia
Allodynia
Glial cells
title The therapeutic effects of transferring remote ischemic preconditioning serum in rats with neuropathic pain symptoms
title_full The therapeutic effects of transferring remote ischemic preconditioning serum in rats with neuropathic pain symptoms
title_fullStr The therapeutic effects of transferring remote ischemic preconditioning serum in rats with neuropathic pain symptoms
title_full_unstemmed The therapeutic effects of transferring remote ischemic preconditioning serum in rats with neuropathic pain symptoms
title_short The therapeutic effects of transferring remote ischemic preconditioning serum in rats with neuropathic pain symptoms
title_sort therapeutic effects of transferring remote ischemic preconditioning serum in rats with neuropathic pain symptoms
topic Neuropathic pain
Remote ischemic preconditioning
Hyperalgesia
Allodynia
Glial cells
url http://www.sciencedirect.com/science/article/pii/S2405844023081628
work_keys_str_mv AT ozgurgunduz thetherapeuticeffectsoftransferringremoteischemicpreconditioningseruminratswithneuropathicpainsymptoms
AT zekiyegulfemyurtgezen thetherapeuticeffectsoftransferringremoteischemicpreconditioningseruminratswithneuropathicpainsymptoms
AT ruhandeniztopuz thetherapeuticeffectsoftransferringremoteischemicpreconditioningseruminratswithneuropathicpainsymptoms
AT melikesapmazmetin thetherapeuticeffectsoftransferringremoteischemicpreconditioningseruminratswithneuropathicpainsymptoms
AT oktaykaya thetherapeuticeffectsoftransferringremoteischemicpreconditioningseruminratswithneuropathicpainsymptoms
AT abdullaherkanorhan thetherapeuticeffectsoftransferringremoteischemicpreconditioningseruminratswithneuropathicpainsymptoms
AT ahmetulugol thetherapeuticeffectsoftransferringremoteischemicpreconditioningseruminratswithneuropathicpainsymptoms
AT ozgurgunduz therapeuticeffectsoftransferringremoteischemicpreconditioningseruminratswithneuropathicpainsymptoms
AT zekiyegulfemyurtgezen therapeuticeffectsoftransferringremoteischemicpreconditioningseruminratswithneuropathicpainsymptoms
AT ruhandeniztopuz therapeuticeffectsoftransferringremoteischemicpreconditioningseruminratswithneuropathicpainsymptoms
AT melikesapmazmetin therapeuticeffectsoftransferringremoteischemicpreconditioningseruminratswithneuropathicpainsymptoms
AT oktaykaya therapeuticeffectsoftransferringremoteischemicpreconditioningseruminratswithneuropathicpainsymptoms
AT abdullaherkanorhan therapeuticeffectsoftransferringremoteischemicpreconditioningseruminratswithneuropathicpainsymptoms
AT ahmetulugol therapeuticeffectsoftransferringremoteischemicpreconditioningseruminratswithneuropathicpainsymptoms